NCT02175251 Low and High Frequency Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Resistant Auditory Hallucination in Schizophrenia Status COMPLETED Phase NA
NCT02174523 Pharmacokinetic Study of Lurasidone After Multiple Oral Administration in Healthy Human Subjects Status COMPLETED Phase PHASE1
NCT02174510 A Pharmacokinetic Study of Lurasidone After Single Oral Administration in Healthy Subjects Status COMPLETED Phase PHASE1
NCT02170051 Improving Negative Symptoms of Psychosis In Real-world Environments Status COMPLETED Phase NA
NCT02167724 Multicentre Evaluation of Bucco-dental Health in Patients With Schizophrenia in Côte d'Or Status COMPLETED Phase NA
NCT02167620 Metformin in Co-morbid Diabetes or Prediabetes and Serious Mental Illness Status COMPLETED Phase PHASE4
NCT02166918 Factors Influencing Social Functioning of People With Schizophrenia Status COMPLETED Phase N/A
NCT02164981 A Proof of Concept Study of Intravenous Sodium Nitroprusside in Adults With Symptomatic Schizophrenia Status COMPLETED Phase PHASE2
NCT02161718 A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder Status COMPLETED Phase PHASE2
NCT02160249 RISE (Rehabilitation Intervention for People With Schizophrenia in Ethiopia) Status COMPLETED Phase NA
NCT02149823 Examining Dose-Related Effects of Oxytocin on Social Cognition Across Populations Status TERMINATED Phase PHASE1
NCT02144155 Open-label Study of the Efficacy of Intranasal Oxytocin in Schizophrenia Status TERMINATED Phase NA
NCT02142556 The Efficacy and Safety of Quetiapine XR in Patients With Schizophrenia Switched From Other Antipsychotics Status COMPLETED Phase PHASE3
NCT02140788 Effects of Metformin and Fish Oil on Treatment With Clozapine Status TERMINATED Phase PHASE4
NCT02137993 Efficacy and Safety of A-prexa Compared to Zyprexa in Patients With Schizophrenia Status COMPLETED Phase PHASE4